Fate Therapeutics
FATE
FATE
37 hedge funds and large institutions have $57.9M invested in Fate Therapeutics in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
8% less funds holding
Funds holding: 40 → 37 (-3)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
37
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.44M | |
| 2 | +$1.87M | |
| 3 | +$1.4M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$212K |
| 5 |
Renaissance Technologies
New York
|
+$55K |
Top Sellers
| 1 | -$1.84M | |
| 2 | -$908K | |
| 3 | -$768K | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$532K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$140K |